Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000886163-23-000019
Filing Date
2023-04-20
Accepted
2023-04-20 16:07:16
Documents
4

Document Format Files

Seq Description Document Type Size
1 DEFA14A ligand-2023proxysupplement.htm DEFA14A 9915
2 a2023proxysupplement1of2.jpg GRAPHIC 342690
3 a2023proxysupplement2of2.jpg GRAPHIC 267813
4 image_0.jpg GRAPHIC 12141
  Complete submission text file 0000886163-23-000019.txt   852458
Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

EIN.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-33093 | Film No.: 23833176
SIC: 2834 Pharmaceutical Preparations